Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT02905318 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02905318
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-04
- Primary completion
- 2022-04-29
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.